Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1059-85-4
2. 5-cholesten-3-alpha-ol Acetate
3. 3596sfa73e
4. [(3r,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate
5. Unii-3596sfa73e
6. Antimony(iii)oxide
7. 3alpha-acetoxycholest-5-ene
8. Epicholesteryl Acetate
9. 3alpha-acetoxycholesta-5-ene
10. Schembl6300400
11. 3.alpha.-acetylcholesterin
12. Epicholesterol Acetate [mi]
13. Zinc26255326
14. Epicholesterol Acetate, (-)-
15. 3.alpha.-acetoxycholest-5-ene
16. Cholest-5-en-3-ol,acetate,(3a)-(9ci)
17. Cholest-5-en-3-ol,acetate, (3a)- (9ci)
18. Q27256446
19. Cholest-5-en-3-ol, 3-acetate, (3.alpha.)-
| Molecular Weight | 428.7 g/mol |
|---|---|
| Molecular Formula | C29H48O2 |
| XLogP3 | 9.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 2 |
| Rotatable Bond Count | 7 |
| Exact Mass | 428.365430770 g/mol |
| Monoisotopic Mass | 428.365430770 g/mol |
| Topological Polar Surface Area | 26.3 Ų |
| Heavy Atom Count | 31 |
| Formal Charge | 0 |
| Complexity | 693 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 8 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Listed Suppliers
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]ABOUT THIS PAGE
A Cholesteryl Acetate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Cholesteryl Acetate, including repackagers and relabelers. The FDA regulates Cholesteryl Acetate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Cholesteryl Acetate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Cholesteryl Acetate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Cholesteryl Acetate supplier is an individual or a company that provides Cholesteryl Acetate active pharmaceutical ingredient (API) or Cholesteryl Acetate finished formulations upon request. The Cholesteryl Acetate suppliers may include Cholesteryl Acetate API manufacturers, exporters, distributors and traders.
click here to find a list of Cholesteryl Acetate suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Cholesteryl Acetate DMF (Drug Master File) is a document detailing the whole manufacturing process of Cholesteryl Acetate active pharmaceutical ingredient (API) in detail. Different forms of Cholesteryl Acetate DMFs exist exist since differing nations have different regulations, such as Cholesteryl Acetate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Cholesteryl Acetate DMF submitted to regulatory agencies in the US is known as a USDMF. Cholesteryl Acetate USDMF includes data on Cholesteryl Acetate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Cholesteryl Acetate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Cholesteryl Acetate suppliers with USDMF on PharmaCompass.
Cholesteryl Acetate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Cholesteryl Acetate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Cholesteryl Acetate GMP manufacturer or Cholesteryl Acetate GMP API supplier for your needs.
A Cholesteryl Acetate CoA (Certificate of Analysis) is a formal document that attests to Cholesteryl Acetate's compliance with Cholesteryl Acetate specifications and serves as a tool for batch-level quality control.
Cholesteryl Acetate CoA mostly includes findings from lab analyses of a specific batch. For each Cholesteryl Acetate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Cholesteryl Acetate may be tested according to a variety of international standards, such as European Pharmacopoeia (Cholesteryl Acetate EP), Cholesteryl Acetate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Cholesteryl Acetate USP).
LOOKING FOR A SUPPLIER?
